Patents by Inventor Angelika Riemer

Angelika Riemer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS
    Publication number: 20230272014
    Abstract: The disclosure relates to a composition of nanoparticles as carrier for HPV-derived immunogenic fragments and the use of the composition for medical purposes, in particular for immunoprophylaxis or immunotherapy. The invention also relates to a vaccine containing the composition and/or nanoparticles.
    Type: Application
    Filed: May 12, 2021
    Publication date: August 31, 2023
    Applicants: Life Science Inkubator Betriebs GmbH & Co. KG, Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
    Inventors: Armin KÜBELBECK, Angelika RIEMER, Sebastian KRUSE, Eva FEIDT, Agnieszka GRABOWSKA, Ellen JUNGLAS
  • Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy
    Publication number: 20190241619
    Abstract: The present invention relates to novel amino acid sequences of peptides derived from HPV16 that are able to promiscuously bind to MHC complexes of class II and shorter peptides contained in the promiscuously binding peptides that bind to MHC complexes of class I, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.
    Type: Application
    Filed: April 16, 2019
    Publication date: August 8, 2019
    Inventors: Agnieszka Grabowska, Angelika Riemer
  • Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy
    Publication number: 20180194810
    Abstract: The present invention relates to novel amino acid sequences of peptides derived from HPV 16 that are able to bind to MHC complexes of class II, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 12, 2018
    Inventors: Agnieszka GRABOWSKA, Angelika RIEMER
  • Promiscuous HPV16-derived T helper epitopes for immunotherapy
    Patent number: 9932371
    Abstract: The present invention relates to novel amino acid sequences of peptides derived from HPV16 that are able to bind to MHC complexes of class II, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: April 3, 2018
    Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Agnieszka Grabowska, Angelika Riemer
  • Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy
    Publication number: 20160311861
    Abstract: The present invention relates to novel amino acid sequences of peptides derived from HPV16 that are able to bind to MHC complexes of class II, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 27, 2016
    Applicant: Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts
    Inventors: Agnieszka GRABOWSKA, Angelika RIEMER
  • Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA
    Publication number: 20090304725
    Abstract: The present invention relates to a vaccine against cancerous diseases associated with the carcinoembryonic antigen CEA.
    Type: Application
    Filed: February 5, 2007
    Publication date: December 10, 2009
    Applicant: Medizinische Universitat Wien
    Inventors: Erika Jensen-Jarolim, Kira Brämswig, Angelika Riemer, Christoph Zielinski, Otto Scheiner